Nivolumab诱导的细胞因子释放综合征：病例报告和文献综述

American Journal of Case Reports Pub Date : 2024-03-04 DOI:10.12659/ajcr.941835

Francis Ntwali, Quentin Gilliaux, Patrick M. Honoré

{"title":"Nivolumab诱导的细胞因子释放综合征：病例报告和文献综述","authors":"Francis Ntwali, Quentin Gilliaux, Patrick M. Honoré","doi":"10.12659/ajcr.941835","DOIUrl":null,"url":null,"abstract":"infusion of hydrocortisone. Conclusions: The use of ICIs is expanding. Nivolumab-induced CRS is rarely described but can be severe and lead to multiple organ dysfunction; therefore, intensive care practitioners should be informed about this adverse effect. More studies are needed to better understand this condition and establish treatment guidelines.","PeriodicalId":504238,"journal":{"name":"American Journal of Case Reports","volume":"14 6‐7","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Nivolumab-Induced Cytokine Release Syndrome: A Case Report and Literature Review\",\"authors\":\"Francis Ntwali, Quentin Gilliaux, Patrick M. Honoré\",\"doi\":\"10.12659/ajcr.941835\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"infusion of hydrocortisone. Conclusions: The use of ICIs is expanding. Nivolumab-induced CRS is rarely described but can be severe and lead to multiple organ dysfunction; therefore, intensive care practitioners should be informed about this adverse effect. More studies are needed to better understand this condition and establish treatment guidelines.\",\"PeriodicalId\":504238,\"journal\":{\"name\":\"American Journal of Case Reports\",\"volume\":\"14 6‐7\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Case Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12659/ajcr.941835\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12659/ajcr.941835","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

输注氢化可的松。结论ICIs 的使用正在不断扩大。Nivolumab诱导的CRS很少见，但可能很严重并导致多器官功能障碍；因此，重症监护医生应了解这种不良反应。需要进行更多的研究，以更好地了解这种情况并制定治疗指南。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Nivolumab-Induced Cytokine Release Syndrome: A Case Report and Literature Review

infusion of hydrocortisone. Conclusions: The use of ICIs is expanding. Nivolumab-induced CRS is rarely described but can be severe and lead to multiple organ dysfunction; therefore, intensive care practitioners should be informed about this adverse effect. More studies are needed to better understand this condition and establish treatment guidelines.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

American Journal of Case Reports

自引率

0.00%

发文量